Skip to main content
Professional Technical IVT

gastroenteropancreatic neuroendocrine tumor

Neuroendocrine tumor arising from the digestive system, including stomach, intestines, and pancreas.

Full Definition

Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a diverse group of neuroendocrine tumors originating from the enterochromaffin cells and related neuroendocrine cells within the gastrointestinal tract and pancreas. These tumors are classified based on their anatomical location (foregut, midgut, hindgut), histological grade, and functional status. GEP-NETs may be functional, producing hormones that cause specific clinical syndromes, or non-functional. The WHO classification system grades these tumors based on proliferative activity (Ki-67 index and mitotic count). Treatment approaches include surgical resection, somatostatin analogs, peptide receptor radionuclide therapy, and systemic therapies depending on tumor characteristics and stage.

Usage

Usage note: Often abbreviated as GEP-NET; hyphenate the full term when used as compound modifier.

In Context

  • "The pathology confirmed a grade 2 gastroenteropancreatic neuroendocrine tumor of the duodenum." — Pathology report
  • "Octreotide therapy was initiated for the metastatic gastroenteropancreatic neuroendocrine tumor." — Treatment plan

Also known as

GEP-NET digestive neuroendocrine tumor

Don't confuse with

pancreatic adenocarcinoma carcinoid tumor gastrointestinal stromal tumor

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON